PT - JOURNAL ARTICLE AU - Adalberto Campo-Arias AU - Leynin Esther Caamano-Rocha AU - John Carlos Pedrozo-Pupo TI - Spanish Version of the Attitude Towards COVID-19 Vaccines Scale: Reliability and Validity Assessment AID - 10.1101/2021.07.18.21260733 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.18.21260733 4099 - http://medrxiv.org/content/early/2021/07/22/2021.07.18.21260733.short 4100 - http://medrxiv.org/content/early/2021/07/22/2021.07.18.21260733.full AB - Background and purpose: The negative attitude to vaccines for coronavirus disease (COVID-19) has motivated the adaptation of instruments for this specific purpose. However, details of the reliability and validity of these scales are unknown. The study aimed to evaluate some indicators of the reliability and validity of the Spanish version of the Attitude towards COVID-19 Vaccines Scale. Methods: A validation study was carried out with 1,136 students of emerging age (18 and 29 years) from a Colombian university; 65.5% were female. Cronbach's alpha and McDonald's omega were calculated for reliability, and exploratory and confirmatory factor analyzes for validity. Additionally, the gender differential item functioning (DIF) was estimated with Kendall's tau b. Results: The Spanish version of Attitude towards COVID-19 Vaccines Scale showed high internal consistency (Cronbach's alpha of 0.94 and McDonald's omega of 0.95), a one-dimensional structure with acceptable goodness-of-fit indicators (CFI=0.94, TLI=0.91, and SRMR=0.04), and non-gender DIF (Kendall's tau b between 0.02 and 0.06). Conclusions: The Spanish version of the Attitude towards COVID-19 Vaccines Scale presents some appropriate reliability and validity indicators among university emerging adults. These findings should be explored in samples with other characteristics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUniversidad del Magdalena, Magdalena, Santa Marta, Colombia.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Board approved the project of the Universidad del Magdalena, Colombia (Act 002 of the ordinary meeting of March 26th, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.